Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes.

Christensen M, Calanna S, Sparre-Ulrich AH, Kristensen PL, Rosenkilde MM, Faber J, Purrello F, van Hall G, Holst JJ, Vilsbøll T, Knop FK.

Diabetes. 2014 Jul 22. pii: DB_140440. [Epub ahead of print]

PMID:
25053587
[PubMed - as supplied by publisher]
2.

Sevelamer in a Diabetologist's Perspective - a Phosphate-Binding Resin with Glucose-Lowering Potential?

Brønden A, Hansen M, Sonne DP, Rohde U, Vilsbøll T, Knop FK.

Diabetes Obes Metab. 2014 Jul 9. doi: 10.1111/dom.12355. [Epub ahead of print]

PMID:
25041567
[PubMed - as supplied by publisher]
3.

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies.

Bak MJ, Wewer Albrechtsen NJ, Pedersen J, Knop FK, Vilsbøll T, Jørgensen NB, Hartmann B, Deacon CF, Dragsted LO, Holst JJ.

Diabetes Obes Metab. 2014 Jul 7. doi: 10.1111/dom.12352. [Epub ahead of print]

PMID:
25041349
[PubMed - as supplied by publisher]
4.

The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract.

Rhee NA, Vilmann P, Hassan H, Hendel JW, Holst JJ, Vilsbøll T, Knop FK.

Scand J Gastroenterol. 2014 Jul 7:1-7. [Epub ahead of print]

PMID:
24998781
[PubMed - as supplied by publisher]
5.

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide-1.

Sonne DP, Rehfeld J, Holst JJ, Vilsbøll T, Knop FK.

Eur J Endocrinol. 2014 Jul 1. pii: EJE-14-0309. [Epub ahead of print]

PMID:
24986531
[PubMed - as supplied by publisher]
6.

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.

Rhee NA, Ostoft SH, Holst JJ, Deacon CF, Vilsbøll T, Knop FK.

Eur J Endocrinol. 2014 Sep;171(3):353-62. doi: 10.1530/EJE-14-0314. Epub 2014 Jun 16.

PMID:
24935932
[PubMed - in process]
7.

Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial.

Ostoft SH, Bagger JI, Hansen T, Pedersen O, Faber J, Holst JJ, Knop FK, Vilsbøll T.

Diabetes Care. 2014 Jul;37(7):1797-805. doi: 10.2337/dc13-3007.

PMID:
24929431
[PubMed - in process]
8.

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

Wewer Albrechtsen NJ, Hartmann B, Veedfald S, Windeløv JA, Plamboeck A, Bojsen-Møller KN, Idorn T, Feldt-Rasmussen B, Knop FK, Vilsbøll T, Madsbad S, Deacon CF, Holst JJ.

Diabetologia. 2014 Jun 3. [Epub ahead of print]

PMID:
24891019
[PubMed - as supplied by publisher]
9.

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report.

Knop FK, Lund A, Madsbad S, Holst JJ, Krarup T, Vilsbøll T.

BMC Res Notes. 2014 May 31;7:326. doi: 10.1186/1756-0500-7-326.

PMID:
24885055
[PubMed - in process]
Free PMC Article
10.

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.

Bagger JI, Knop FK, Lund A, Holst JJ, Vilsbøll T.

Diabetologia. 2014 Aug;57(8):1720-5. doi: 10.1007/s00125-014-3264-2. Epub 2014 May 31.

PMID:
24879388
[PubMed - in process]
11.

MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.

Sonne DP, Hansen M, Knop FK.

Eur J Endocrinol. 2014 Aug;171(2):R47-R65. Epub 2014 Apr 23. Review.

PMID:
24760535
[PubMed - as supplied by publisher]
Free Article
12.

Elimination and Degradation of Glucagon-like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Patients with End-Stage Renal Disease.

Idorn T, Knop FK, Jørgensen MB, Christensen M, Holst JJ, Hornum M, Feldt-Rasmussen B.

J Clin Endocrinol Metab. 2014 Jul;99(7):2457-66. doi: 10.1210/jc.2013-3809. Epub 2014 Apr 8.

PMID:
24712563
[PubMed - in process]
13.

Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities.

Lund A, Knop FK, Vilsbøll T.

Eur J Intern Med. 2014 Jun;25(5):407-14. doi: 10.1016/j.ejim.2014.03.005. Epub 2014 Mar 30.

PMID:
24694879
[PubMed - in process]
14.

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young-type 2 and type 3.

Ostoft SH, Bagger JI, Hansen T, Pedersen O, Holst JJ, Knop FK, Vilsbøll T.

Diabetes. 2014 Aug;63(8):2838-44. doi: 10.2337/db13-1878. Epub 2014 Mar 27.

PMID:
24677712
[PubMed - in process]
Free Article
15.

Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, Purrello F.

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):670-6. doi: 10.1016/j.numecd.2014.01.013. Epub 2014 Jan 29.

PMID:
24656139
[PubMed - in process]
16.

[Gut microbiota may have influence on glucose and lipid metabolism.]

Mikkelsen KH, Nielsen MF, Tvede M, Hansen T, Pedersen OB, Holst JJ, Vilsbøll T, Knop FK.

Ugeskr Laeger. 2013 Nov 11;175(46):2785-2788. Danish.

PMID:
24629316
[PubMed - as supplied by publisher]
17.

Decreased plasma chemerin levels in women with gestational diabetes mellitus.

Hare KJ, Bonde L, Svare JA, Randeva HS, Asmar M, Larsen S, Vilsbøll T, Knop FK.

Diabet Med. 2014 Aug;31(8):936-40. doi: 10.1111/dme.12436. Epub 2014 Apr 1.

PMID:
24628007
[PubMed - in process]
18.

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

Hansen M, Sonne DP, Knop FK.

Curr Diab Rep. 2014 May;14(5):482. doi: 10.1007/s11892-014-0482-4.

PMID:
24623198
[PubMed - in process]
19.

Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, Purrello F.

Acta Diabetol. 2014 Jan 18. [Epub ahead of print]

PMID:
24442427
[PubMed - as supplied by publisher]
20.

Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.

Christensen MB, Calanna S, Holst JJ, Vilsbøll T, Knop FK.

J Clin Endocrinol Metab. 2014 Mar;99(3):E418-26. doi: 10.1210/jc.2013-3644. Epub 2013 Dec 11.

PMID:
24423311
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk